Dalia Rotstein, MD, MPH, assistant professor of medicine at the University of Toronto, lists barriers to multiple sclerosis (MS) research and care delivery.
Dalia Rotstein, MD, MPH, assistant professor of medicine at the University of Toronto, lists barriers to multiple sclerosis (MS) research and care delivery.
The topic was discussed on February 29 at the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2024 during the session Rotstein cochaired titled "MS Across Populations and Access to Care."
Transcript
What specific barriers are there to equitable MS research and care delivery?
I think we are facing many barriers today to equitable MS care and also to research. Firstly, I think we have to consider different social determinants of health, and, as highlighted in this session, access to neurologic care is also a key factor.
So, social determinants of health include factors like income, sex, age, race, and ethnicity; also, what the built environment looks like. So, what does the neighborhood that a person lives in look like in terms of access to medical centers, availability of nutritious food, and community support; are they in a situation with social isolation?
All of these factors are very important when we're considering equity goals. I think that, as we saw in recent research that was highlighted by [Marisa McGinley, DO, of Cleveland Clinic], there are many disparities. We observed disparities and access to neurologic care across rural and urban communities in the United States and also across different racial and ethnic communities. The Hispanic and Black communities have lower access to specialized neurologic care, especially MS neurologists.
We need to think about creative solutions for approaching that. I think it's important to engage those different communities and try to find out how we can deliver care in a more accessible manner. Also, there were some novel solutions proposed, such as using telemedicine, for example, to reach people in a more convenient way. I think there are a lot of promising avenues for the future, but there's a lot of work that needs to be done.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More